Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Review of the Historical Literature and Its Role in the Era of Targeted Molecular Therapy

Table 1

Trial	No. of patients	Median survival (months)		P value	Response to therapy (%)		P
		IFN	Surgery + IFN		IFN	Surgery + IFN
SWOG	241	8.1	11.1	0.05	3.3	3.6	NS
EORTC	85	7	17	0.03	12	19	0.38